BRIEF published on 04/17/2025 at 15:27, 1 year 4 months ago Vanguard Group Discloses Position in Qualcomm Form 8.3 Takeover Code Vanguard Group Investment Disclosure Qualcomm
BRIEF published on 04/17/2025 at 15:26, 1 year 4 months ago Vanguard Group's Disclosure of Stake in American Axle & Manufacturing Takeover Code Securities Disclosure Vanguard Group Shareholding American Axle
BRIEF published on 04/17/2025 at 15:25, 1 year 4 months ago The Vanguard Group Discloses Position in Mural Oncology plc Form 8.3 Disclosure The Vanguard Group Irish Takeover Mural Oncology
BRIEF published on 04/17/2025 at 15:24, 1 year 4 months ago The Vanguard Group Discloses Stake in Assura plc The Vanguard Group Takeover Code Securities Disclosure Stock Holdings Assura Plc
BRIEF published on 04/17/2025 at 15:23, 1 year 4 months ago The Vanguard Group Discloses Stake in Aviva plc Disclosure Takeover Code Vanguard Group Shareholding Aviva Plc
PRESS RELEASE published on 04/17/2025 at 15:22, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.50% stake in Qualcomm Incorporated as per Form 8.3 filing Form 8.3 Disclosure Vanguard Group Stake Qualcomm
BRIEF published on 04/17/2025 at 15:22, 1 year 4 months ago The Vanguard Group Discloses Position in Alphawave IP Securities Takeover Code Vanguard Qualcomm Alphawave IP
PRESS RELEASE published on 04/17/2025 at 15:21, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 11.27% stake in American Axle & Manufacturing Holdings, Inc. as of 16 April 2025 Vanguard Group Stake Disclosure Financial Holdings Stock Positions American Axle
PRESS RELEASE published on 04/17/2025 at 15:20, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 4.47% interest in Mural Oncology plc's ordinary shares as per Form 8.3 filed with the Irish Takeover Panel on 17-Apr-2025 Form 8.3 Disclosure Irish Takeover Panel Vanguard Group Inc. Mural Oncology Plc
PRESS RELEASE published on 04/17/2025 at 15:19, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Assura plc The Vanguard Group, Inc. discloses a 5.61% stake in Assura plc through relevant securities. Purchase of 10p ordinary shares made at 0.48 GBP per unit The Vanguard Group, Inc. Relevant Securities Purchase Stake Disclosure Assura Plc
Published on 09/12/2026 at 02:35, 7 hours 26 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 11 hours 1 minute ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 11 hours 56 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 12 hours 36 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 17 hours 1 minute ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 2 hours 30 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 11 hours 46 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 11 hours 50 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 14 hours 16 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 15 hours 45 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 3 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 14 hours ago Availability of the 2026 Interim Financial Report
